J. Heyward Hull

989 total citations
29 papers, 767 citations indexed

About

J. Heyward Hull is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, J. Heyward Hull has authored 29 papers receiving a total of 767 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 5 papers in Cardiology and Cardiovascular Medicine and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in J. Heyward Hull's work include Pharmacogenetics and Drug Metabolism (6 papers), Pharmaceutical studies and practices (5 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). J. Heyward Hull is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Pharmaceutical studies and practices (5 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). J. Heyward Hull collaborates with scholars based in United States, Netherlands and Jamaica. J. Heyward Hull's co-authors include Lawrence J. Hak, Albert M. Mattocks, William A. Wargin, Gary G. Koch, Jean H. Bowdre, David M. Cocchetto, Kenneth I. Ataga, Frederic Galactéros, Abdullah Kutlar and Carolyn Bigelow and has published in prestigious journals such as Kidney International, Journal of Pharmacology and Experimental Therapeutics and Journal of Pharmaceutical Sciences.

In The Last Decade

J. Heyward Hull

29 papers receiving 711 citations

Peers

Countries citing papers authored by J. Heyward Hull

Since Specialization

Citations

This map shows the geographic impact of J. Heyward Hull's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Heyward Hull with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Heyward Hull more than expected).

Fields of papers citing papers by J. Heyward Hull

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Heyward Hull. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Heyward Hull. The network helps show where J. Heyward Hull may publish in the future.

Co-authorship network of co-authors of J. Heyward Hull

This figure shows the co-authorship network connecting the top 25 collaborators of J. Heyward Hull. A scholar is included among the top collaborators of J. Heyward Hull based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Heyward Hull. J. Heyward Hull is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparison of tenofovir plasma and tissue exposure using a population pharmacokinetic model and bootstrap: a simulation study from observed data 2017 ·Journal of Pharmacokinetics and Pharmacodynamics ·(unknown), J. Heyward Hull, Julie B. Dumond	4
2	Assessment of a Candidate Marker Constituent Predictive of a Dietary Substance–Drug Interaction: Case Study with Grapefruit Juice and CYP3A4 Drug Substrates 2014 ·Journal of Pharmacology and Experimental Therapeutics ·Garrett R. Ainslie, Kristina Wolf, Yingxin Li, Elizabeth A. Connolly, Yolanda V. Scarlett, J. Heyward Hull, Mary F. Paine	10
3	Relative bioavailability of tolvaptan administered via nasogastric tube and tolvaptan tablets swallowed intact 2013 ·American Journal of Health-System Pharmacy ·(unknown), (unknown), Kirkwood F. Adams, J. Heyward Hull, Brian Simmons, (unknown), Kim L. R. Brouwer, J. Herbert Patterson	7
4	The Influence of Sex, Ethnicity, and CYP2B6 Genotype on Bupropion Metabolism as an Index of Hepatic CYP2B6 Activity in Humans 2012 ·Drug Metabolism and Disposition ·Katarina Ilić, Roy L. Hawke, Ranjit K. Thirumaran, Erin G. Schuetz, J. Heyward Hull, Angela D. M. Kashuba, Paul W. Stewart, Celeste Lindley, Mei-Ling Chen	21
5	Pilot study of rosiglitazone as an in vivo probe of paclitaxel exposure 2012 ·British Journal of Clinical Pharmacology ·Daniel L. Hertz, Christine M. Walko, Arlene S. Bridges, J. Heyward Hull, (unknown), Kristan Rollins, Paul B. Watkins, E. Claire Dees	7
6	The effect of aprepitant and race on the pharmacokinetics of cyclophosphamide in breast cancer patients 2012 ·Cancer Chemotherapy and Pharmacology ·Christine M. Walko, Austin J. Combest, Ivan Spasojević, Angela Yu, (unknown), J. Heyward Hull, Janelle M. Hoskins, (unknown), Lisa A. Carey, (unknown), Elizabeth Claire Dees	17
7	Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso‐occlusive crises in patients with sickle cell disease: a phase III randomized, placebo‐controlled, double‐blind study of the gardos channel blocker senicapoc (ICA‐17043) 2011 ·British Journal of Haematology ·Kenneth I. Ataga, Marvin Reid, Samir K. Ballas, Zahida Yasin, Carolyn Bigelow, (unknown), Wally R. Smith, Frederic Galactéros, Abdullah Kutlar, J. Heyward Hull, Jonathan W. Stocker, (unknown)	160
8	Absorption of Digoxin from Tablets and Capsules in Subjects with Malabsorption Syndromes 1989 ·DICP ·W. Heizer, (unknown), (unknown), (unknown), (unknown), J. Heyward Hull	8
9	Factors Associated With Nephrotoxicity and Clinical Outcome in Patients Receiving Amikacin 1986 ·The Journal of Clinical Pharmacology ·Paul J. Williams, J. Heyward Hull, Felix A. Sarubbi, John F. Rogers, William A. Wargin	9
10	Effect of metoclopramide on digoxin absorption from tablets and capsules 1984 ·Clinical Pharmacology & Therapeutics ·Brian F. G. Johnson, (unknown), David R. Urbach, J. Heyward Hull, (unknown)	28
11	A pocket calculator program for pharmacokinetic dosing of drugs exhibiting single compartment first-order elimination and zero-order or first-order absorption 1984 ·Computers and Biomedical Research ·Denis F. Hochstrasser, (unknown), J. Heyward Hull, Felix A. Sarubbi	2
12	Antibiotic efficacy against Vibrio vulnificus in the mouse: superiority of tetracycline. 1983 ·Journal of Pharmacology and Experimental Therapeutics ·Jean H. Bowdre, J. Heyward Hull, David M. Cocchetto	62
13	Training the “Clinical Scientist” Through a Combined Industrial/Academic Fellowship 1983 ·American Journal of Pharmaceutical Education ·J. Heyward Hull, Allen Cato, Gilles Cloutier, (unknown), (unknown)	5
14	A routine method for the determination of digoxin in urine by radioimmunoassay 1982 ·Clinica Chimica Acta ·Robert H. Christenson, (unknown), J. Heyward Hull, (unknown)	7
15	An Evaluation of the Effects of Smoking on Codeine Pharmacokinetics and Bioavailability in Normal Human Volunteers 1982 ·Drug Intelligence & Clinical Pharmacy ·J. Heyward Hull, John W. A. Findlay, John F. Rogers, Richard M. Welch, Robert F. Butz, (unknown)	8
16	Influence of range of renal function and liver disease on predictability of creatinine clearance 1981 ·Clinical Pharmacology & Therapeutics ·J. Heyward Hull, Lawrence J. Hak, Gary G. Koch, William A. Wargin, (unknown), Albert M. Mattocks	126
17	Enhancement of peritoneal dialysis clearance with docusate sodium 1981 ·Kidney International ·(unknown), Lawrence J. Hak, J. Heyward Hull, Albert M. Mattocks	14
18	Mathematical Considerations in the Estimation of Peak Drug Concentrations Under Uniform and Nonuniform Dosing Conditions 1980 ·The Journal of Clinical Pharmacology ·J. Heyward Hull	2
19	The Effect of Disease States on Drug Pharmacokinetics 1977 ·American Journal of Health-System Pharmacy ·J. Heyward Hull	132
20	Evaluation of the Pharmacist as a Drug Therapy Advisor on Ward Rounds 1973 ·American Journal of Health-System Pharmacy ·J. Heyward Hull, (unknown)	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact